TrialJournal of neuro-oncology2008

Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma.

J F de Groot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.